the treatment of certain cancer and degenerative diseases. Our developmental stem cell, progenitor cell, and immune cell projects are the result of collaborative research and development between scientists and doctors from the U.S. and
China. Our flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and managed according to U.S. standards. To learn more about CBMG, please visit:
www.cellbiomedgroup.com About EastBridge
EastBridge Investment Group focuses on high-growth companies in Asia and in the United States, offering assistance with all aspects of IPOs, joint ventures and merchant banking services. EastBridge targets industries in the fields of electronics, real estate, auto, metal, energy, environmental, bioscience and retail food distribution. To learn more about EastBridge Investment Group go to our web site: www.EbigCorp.com. To receive EBIG's email alert, send a blank email to info@EbigCorp.com.
Forward-Looking Statements
Statements in this press release relating to plans, strategies, trends, specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-lookin
'/>"/>
SOURCE EastBridge Investment Group Corporation Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
EastBridge Investment Group and CBMG attended SeeThruEquity Investor Conference in New York2.
Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe3.
Axela Inc. Retains Investment Bank to Evaluate Strategic Opportunities4.
Analysis of Venture Capital Investment Trends in the North American and European Healthcare Industry5.
Kansas Bioscience Authority Approves $700,000 in Investments6.
David Lichtenstein: Biotechnology is Rich Area for Investment7.
Israeli Ministry of Finance Hosts Israel Investment, Innovation and Trade Forum in New York8.
Foundation Venture Capital Group Makes Eighth Start-Up Investment9.
Regenerative Sciences Receives $2M Investment for Orthopedic Stem Cell Initiatives10.
Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference11.
City of Mason and Top Gun Sales Performance Announce $4 Million Investment In New Corporate Headquarters